B. Riley Downgrades Allscripts Healthcare Solutions to Sell (MDRX)
Allscripts Healthcare Solutions (NASDAQ:MDRX) was downgraded by analysts at B. Riley from a “neutral” rating to a “sell” rating in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports.
Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 15.34 on Monday. Allscripts Healthcare Solutions has a 52-week low of $9.41 and a 52-week high of $16.43. The stock has a 50-day moving average of $14.99 and a 200-day moving average of $14.79. The company’s market cap is $2.733 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.03. The company had revenue of $334.00 million for the quarter, compared to the consensus estimate of $355.30 million. During the same quarter in the previous year, the company posted $0.23 earnings per share. The company’s revenue for the quarter was down 7.5% on a year-over-year basis. Analysts expect that Allscripts Healthcare Solutions will post $0.27 EPS for the current fiscal year.
A number of other firms have also recently commented on MDRX. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Monday, December 9th. They set an “overweight” rating and a $18.00 price target on the stock. Separately, analysts at Deutsche Bank initiated coverage on shares of Allscripts Healthcare Solutions in a research note to investors on Wednesday, November 20th. They set a “buy” rating and a $19.00 price target on the stock. Finally, analysts at Thomson Reuters/Verus upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note to investors on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $16.91.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.